GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NRX Pharmaceuticals Inc (STU:B1Q) » Definitions » Float Percentage Of Total Shares Outstanding

NRX Pharmaceuticals (STU:B1Q) Float Percentage Of Total Shares Outstanding : 70.55% (As of Jun. 21, 2024)


View and export this data going back to 2020. Start your Free Trial

What is NRX Pharmaceuticals Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, NRX Pharmaceuticals's float shares is 6.75 Mil. NRX Pharmaceuticals's total shares outstanding is 9.57 Mil. NRX Pharmaceuticals's float percentage of total shares outstanding is 70.55%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, NRX Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, NRX Pharmaceuticals's Institutional Ownership is 3.66%.

NRX Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

NRX Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=6.75/9.57
=70.55%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

NRX Pharmaceuticals (STU:B1Q) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NRX Pharmaceuticals Inc (STU:B1Q) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
VIRX PIRS ABIO CADL MRKR ENLV NCNA ORGS SRNEQ MTEM OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
NRXP:USA
Address
1201 Orange Street, Suite 600, Wilmington, DE, USA, 19801
Website
https://nrxpharma.com
NRX Pharmaceuticals Inc is a clinical-stage, small molecule pharmaceutical company which develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. It is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behaviour.

NRX Pharmaceuticals (STU:B1Q) Headlines

No Headlines